Search Tag: Hologic

IMAGING Management

Chris Coughlin Elected to Hologic Board of Directors

2016 02 Mar

Hologic, Inc. (Nasdaq: HOLX) has announced that Christopher J. Coughlin has joined the Company's Board of Directors.  Mr. Coughlin was elected to the Board at the Company's 2016 Annual Meeting of Stockholders, along with nine existing Directors who were re-elected.Mr. Coughlin, who in December was named "Director of the Year" by the National Association... Read more

IMAGING Management

Hologic to Showcase Award-Winning Breast Screening and Interventional Solutions at RSNA

2016 27 Nov

--New products spotlight Hologic's leading tomosynthesis technology, including the world's first dedicated prone biopsy system with 2D or 3D™ imaging--Hologic, Inc. (Nasdaq: HOLX) will highlight its portfolio of innovative, award-winning breast cancer screening and interventional products, including the new Affirm™ prone breast biopsy system, at the... Read more

IMAGING Management

Hologic Announces Upcoming Put Option & Notice of Redemption

2016 10 Nov

Hologic, Inc. (Nasdaq: HOLX) has announced that holders of the 2.00% Convertible Exchange Senior Notes due 2037 (CUSIP No. 436440 AB7) issued November 23, 2010 have the right to surrender their notes for repurchase by the Company.  This right is pursuant to the put option under the base indenture governing the notes dated December 10, 2007, as supplemented... Read more

IMAGING Management

Hologic to Webcast Presentations at Upcoming Investor Conferences

2016 08 Nov

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at three upcoming investor conferences:The Stifel 2016 Healthcare Conference in New York on Wednesday, November 16 at 2:15 p.m. Eastern Time (ET).The Canaccord Genuity Medical Technologies and Diagnostics Forum 2016 in New York on Thursday, November 17 at 1 p.m. ET.The 28th Read more

IMAGING Management

First Reviews of New Hologic Affirm™ Prone Biopsy System are Very Positive

2016 06 Nov

Breast tomosynthesis exams, Hologic calls the exams 3D MAMMOGRAPHY, have shown to be an advance over digital mammography, with higher cancer detection rates and fewer patient recalls for additional testing   The new Affirm prone system, which was installed for the first time in Europe earlier this year, is widely considered one the most significant... Read more

IMAGING Management

Hologic Announces Financial Results for Fourth Quarter of Fiscal 2016

2016 03 Nov

- GAAP Diluted EPS of $0.33 Increases 266.7%, Non-GAAP Diluted EPS of $0.52 Increases 20.9% -- Revenue of $726.8 Million Grows 3.4%, 3.8% in Constant Currency -- In Fiscal 2017, Company Expects Mid-Single-Digit Revenue Growth, EPS Growth Roughly Double this Rate -Hologic, Inc. (Nasdaq: HOLX) has announced the Company's financial results for the fiscal... Read more

IMAGING Management

Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2016 on November 2, 2016

2016 04 Oct

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the fourth quarter of fiscal 2016 on Wednesday, November 2, 2016, after the market closes.  In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.Interested participants may listen to the call... Read more

IMAGING Management

Hologic Notice that Holders of 2% Convertible Exchange Senior Notes Due 2037 are Eligible to Convert

2016 04 Oct

Hologic, Inc. (Nasdaq: HOLX) has announced that it has notified holders of the 2.00% Convertible Exchange Senior Notes due 2037 (CUSIP No. 436440 AB7) issued November 23, 2010, and Wilmington Trust Company, the trustee, paying agent and conversion agent for the notes, that holders are eligible to convert the notes. This conversion right is subject to... Read more

IMAGING Management

Hologic CEO Steve MacMillan & Sheryl Crow Will Be Ringing the Nasdaq Opening Bell on October 3

2016 30 Sep

Hologic, Inc. (Nasdaq: HOLX) has announced that breast cancer survivor and Grammy Award-winner Sheryl Crow will join Steve MacMillan, the Company's Chairman, President and Chief Executive Officer, to ring the Nasdaq Opening Bell on October 3, in conjunction with the start of Breast Cancer Awareness Month.Hologic's participation in the bell ringing marks... Read more

IMAGING Management

FDA Expands Use Authorization for Hologic's Aptima® Zika Virus Assay to Use with Urine Sample

2016 09 Sep

Hologic, Inc. (Nasdaq: HOLX) has announced  that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) for the company's Aptima® Zika virus diagnostic assay to be used with urine samples (collected alongside patient-matched serum or plasma specimens).Hologic's Zika virus assay was authorized for emergency use... Read more


Endorsed Companies